Biotechnology - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

226 to 250 of 971 results

Acceleron and Shire not to restart ACE-031 program

03-05-2013

Privately-held US biotech firm Acceleron Pharma says that Ireland-headquartered Shire (LSE: SHP) has…

Acceleron PharmaACE-031BiotechnologyLicensingPharmaceuticalRare diseasesResearchShire

Pharma and biotech industries headed toward era of reduced profit margins

03-05-2013

In the face of reduced profit margins for the pharmaceutical and biotechnology sectors, an effective…

BiotechnologyFinancialMarkets & MarketingPharmaceuticalResearch

FDA advisory votes against AVEO and Astellas' cancer drug tivozanib

03-05-2013

US biotech firm AVEO Oncology (Nasdaq: AVEO) saw its shares plunge as much as 57% in late trading yesterday…

Astellas PharmaAVEO OncologyBiotechnologyNorth AmericaOncologyPharmaceuticalRegulationtivozanib

US and European gastroenterologist's views on hepatitis C treatments

02-05-2013

Gastroenterologists in the USA and Europe by health care advisory firm Decision Resources agree that…

Anti-viralsBiotechnologyEuropeMarkets & MarketingNorth AmericaPharmaceuticalResearch

Generics take toll on Sanofi's 1st-qtr sales, with net profit down 33.5%

02-05-2013

French drug major Sanofi (Euronext: SAN) today (May 2) reported first-quarter 2013 financial results…

BiotechnologyFinancialGenzymePharmaceuticalSanofi

US FDA rejects Titan Pharma's Probuphine NDA

01-05-2013

California, USA-based Titan Pharmaceuticals (OTCBB: TTNP) has received a Complete Response Letter from…

BiotechnologyBraeburn PharmaceuticalsNeurologicalNorth AmericaPharmaceuticalProbuphineRegulationTitan Pharmaceuticals

Soligenix and Intrexon collaborate on Melioidosis therapy development

01-05-2013

US clinical stage biopharma company Soligenix (OTCBB: SNGX) says it will jointly develop a treatment…

Antibiotics and Infectious diseasesBiotechnologyIntrexonLicensingPharmaceuticalResearchSoligenix

Routine cinacalcet for end stage kidney disease not warranted

01-05-2013

Cinacalcet, a drug commonly given to patients with end stage kidney disease to help keep phosphorus and…

AmgenBiotechnologycinacalcetNephrology and HepatologyPharmaceuticalResearchSensipar

FDA approves CSL's Kcentra and accepts Octapharma Octaplex BLA for reversal of anticoagulation

30-04-2013

The US Food and Drug Administration has approved Kcentra (prothrombin complex concentrate, human) from…

BiotechnologyCardio-vascularCSL BehringCSL LimitedKcentraNorth AmericaOctapharmaOctaplexPharmaceuticalRegulation

GlaxoSmithKline files for umeclidinium monotherapy approval in Europe

29-04-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has submitted a regulatory application in the European Union…

BiotechnologyEuropeGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravanceumeclidinium

Janssen files for European approval of hep C candidate simeprevir

25-04-2013

Janssen-Cilag International, a European subsidiary of US health care giant Johnson & Johnson (NYSE: JNJ),…

Anti-viralsBiotechnologyEuropeJanssen-CilagJohnson & JohnsonPharmaceuticalRegulationsimeprevir

Sanofi's Aubagio delayed onset of clinically definite MS in TOPIC study

25-04-2013

French drug major Sanofi (Euronext: SAN) US biotech subsidiary Genzyme announced today positive top-line…

AubagioBiotechnologyGenzymeNeurologicalPharmaceuticalResearchSanofi

OPKO Health to acquire PROLOR Biotech in $480 million stock deal

25-04-2013

Continuing on its acquisitive path, US drugmaker OPKO Health (NYSE: OPK) has signed a definitive agreement…

BiotechnologyMergers & AcquisitionsMetabolicsOPKO HealthPharmaceuticalPROLOR Biotech

Orphan diseases' appeal lies in return on investment, says Evaluate

24-04-2013

For many years, Big Pharma's model of success has been the blockbuster: drugs that sell more than $1…

BiotechnologyFinancialMarkets & MarketingPharmaceuticalRare diseasesResearch

World's first long-lasting hemophilia therapies will see Biogen move ahead of Pfizer and Baxter

23-04-2013

As US biotech company Biogen Idec (Nasdaq: BIIB) prepares to break into the hemophilia market by launching…

BaxterBiogen IdecBiotechnologyMarkets & MarketingPfizerPharmaceutical

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Progress on better access to medicines for patients in Europe

19-04-2013

Significant progress was made in the work of the Process on Corporate Responsibility in the field of…

BiotechnologyEuropeHealthcarePharmaceuticalPricingRegulation

Australian Pharma Patent Review releases draft report for comment

18-04-2013

The Pharmaceutical Patent Review, conducted by an intellectual property Australia-appointed panel, has…

Asia-PacificBiotechnologyPatentsPharmaceutical

226 to 250 of 971 results

Back to top